Seminars in Arthritis and Rheumatism

Article	Citations
Performance of cut-offs of the ASAS Health Index to discriminate between treatment groups in patients with axial spondyloarthritis in the TICOSPA trial	92
Combotherapies in immune-mediated inflammatory diseases: A study using the Clinical Data Warehouse from Paris Hospitals’ Public Assistance	84
Hip and pelvis region MRI reference image atlas for scoring inflammation in peripheral joints and entheses according to the OMERACT-MRI WIPE scoring system in patients with spondyloarthritis	80
Hydroxyquinone use does not increase the risk of venous thromboembolism in rheumatoid arthritis patients—Real-world evidence from a population-based cohort study	58
Response letter to the editor	50
Letter to the editor regarding Outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: A meta-analysis and systematic review	49
Immunotherapy in cancer	47
The Autoantibody response in rheumatoid arthritis; what makes it unique?	44
Looking at Fibromyalgia differently – the meaning and consequences of fibromyalgia as a dimensional disorder	43
OMERACT validation of a deep learning algorithm for automated absolute quantification of knee joint effusion versus manual semi-quantitative assessment	41
Metabolomics in systemic lupus erythematosus: A systematic review and meta-analysis	40
Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes	40
Corrigendum to “Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice” [Seminars in Arthritis and Rheumatism 71 (2025) 152640]	40
Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort	38
Response to the correspondence by Xu et al. regarding "Toward a more actionable RA-ILD risk model"	38
Is mixed connective tissue disease (MCTD) a subtype of systemic sclerosis?	38
Risk prediction models for incident systemic lupus erythematosus among women in the Nurses’ health study cohorts using genetics, family history, and lifestyle and environmental factors	37
mRNA vaccines in the rheumatologist's future	36
Exploring the association between adiposity, pain intensity, and effusion-synovitis in people with knee osteoarthritis: A cross-sectional study	34
A clue for subclinical CNO in adolescents with acne conglobata and hidradenitis suppurativa: Persistan acute phase rectans elevation	33
Refining RA-ILD screening: Diagnostic limitations and the emerging role of lung ultrasound	33
Quantification of coronary artery calcification in systemic sclerosis using visual ordinal and deep learning scoring: Association with systemic sclerosis clinical features	32
Interstitial lung disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis: chest CT patterns and correlation with survival	31
Correspondence to ‘Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors’	31
Survival of adults with rheumatoid arthritis associated interstitial lung disease - A systematic review and meta-analysis	30

Almost half of the patients with axial spondyloarthritis reporting an acceptable symptom state have high disease activity; data from two standard-of-care cohorts	30
OMERACT Core outcome measurement set for shared decision making in rheumatic and musculoskeletal conditions: a scoping review to identify candidate instruments	30
Update on IgG4-related periaortitis/retroperitoneal fibrosis and periarteritis -recent clinical, diagnostic and therapeutic advances	29
Longitudinal changes on cranial magnetic resonance imaging in relapsing giant cell arteritis	28
Is there room for precocious prevention in rheumatoid arthritis precision medicine? A temporal and stratified reframing in diagnostic and therapeutic pathway	28
Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis	28
Assessing domain match and feasibility of candidate instruments matching with OMERACT endorsed domains to measure flare in knee and hip osteoarthritis	27
Response to: Comment to “Vitamin D in psoriatic arthritis—A systematic review and meta-analysis”	27
The state of the Osteoarthritis Initiative (OAI): Entering a new era	27
A population-based analysis of rheumatology care patterns for inflammatory arthritis during COVID-19 in Alberta, Canada	26
Raynaud's phenomenon secondary to central nervous system stimulants: A therapeutic role of α-1 adrenergic blockers?	26
Disease characteristics, co-morbidities and treatment response in a contemporary axial spondyloarthritis cohort: Analysis of 717 patients from the Greek AxSpA registry	25
Interstitial lung disease phenotype in mixed, differentiated, or overlapping, connective tissue diseases: Comment on the article by Boleto et al.	25
Psychological stress in rheumatoid arthritis: a systematic scoping review	25
Corrigendum to “The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time” [Seminars in Arthritis and Rheumatism 55 (2022):152010]	25
A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis	25
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial	25
Prevalence of crystal deposits in asymptomatic hyperuricemia according to different scanning definitions: A comparative study	24
Using patient reported outcomes measurement information system (PROMIS®) measures in rheumatoid arthritis clinical care, research, and trials	24
AA amyloidosis in inflammatory joint diseases: A systematic review	24
Correspondence on “Central sensitization has major impact on quality of life in patients with axial spondyloarthritis” By Kieskamp et al.	24
The clinical features of juvenile dermatomyositis: A single-centre inception cohort	23
A cohort study on the associations between age at natural menopause and rheumatoid arthritis in postmenopausal women from the Canadian Longitudinal Study on Aging	23
Imaging to predict early relapses after treatment discontinuation in patients with large vessel giant cell arteritis – A cohort study	23
Are there causal mucosal drivers in the preclinical development of rheumatoid arthritis?	23
Response to Chen and Liu regarding correspondence to “Development of a prediction model for progression of rheumatoid arthritis–associated interstitial lung disease using serologic and clinical factor	23
Giant cell arteritis associated with scalp, tongue or lip necrosis: A French multicenter case control study	23
Sodium-glucose cotransporter 2 (SGLT2) inhibition and autoimmunity	23
Targeting the Wnt pathway for the treatment of Osteoarthritis of the knee	22
Outcomes of respiratory syncytial virus infection in patients with systemic autoimmune rheumatic disease	22
Hematopoietic stem cell transplant, chimeric antigen receptor T-cells, and other cellular therapies as stepping stones toward long-term improvement in severe scleroderma and other autoimmune diseases	22
Methotrexate treatment in hand osteoarthritis refractory to usual treatments: A randomised, double-blind, placebo-controlled trial	21
Sarcoidosis incidence after mTOR inhibitor treatment	21
Response to commentary on IgG4-related uveitis. A French cohort and literature review	21
Response: Early referral of patients with suspected polymyalgia rheumatica: An active involvement of the out-of-hospital public rheumatologist is needed. Reply letter to Ciro Manzo (letter to the edit	21
Effect of zoledronic acid with or without methylprednisolone on 3D bone area and bone shape in patients with symptomatic knee osteoarthritis: A post-hoc analysis of the ZAP2 trial	21
Looking at fibromyalgia differently – An observational study of the meaning and consequences of fibromyalgia as a dimensional disorder	20
Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of	20
Further expanding the clinical spectrum of giant cell arteritis: Non-classical organ involvement and uncommon complications	20
The role of sex and systemic inflammation in the development of cardiovascular disease in osteoarthritis: A population-based cohort study using the CLSA	20
Defining a personalized treatment approach to rheumatoid arthritis: Using genetic markers of TNFi response	20
Discriminating capacity of the ASAS health index in patients with axial spondyloarthritis treated with ixekizumab	20
Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients	19
Therapeutic approach to central nervous system involvement of Behçet's disease	19
HRCT imaging of pulmonary involvement in granulomatosis with polyangiitis and microscopic polyangiitis at disease onset and during follow-up	19
Improvement of bone mineral density and new vertebral fractures during 8 years of TNF-α inhibition in patients with axial spondyloarthritis	19
Mechanisms of joint pain: Five short lessons from osteoarthritis	18
Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: A systematic review and meta-analysis	18
Is there a role for Pneumocystis jiroveci pneumonia prophylaxis in giant cell arteritis or polymyalgia rheumatica?	18
Causal association of diet-derived circulating antioxidants with the risk of rheumatoid arthritis: A Mendelian randomization study	18

Response to letter to the editor regarding "Nailfold Capillaroscopy as a predictor of cardiovascular events and mortality in systemic sclerosis"	18
Risk factors for invasive fungal infections in patients with connective tissue disease: Systematic review and meta-analysis	18
Systematic review of colchicine neuromyopathy: Risk factors, duration and resolution	17
The autoimmune rheumatological presentation of Common Variable Immunodeficiency Disorders with an overview of genetic testing	17
Pathogenesis and targets in uveitis	17
The Role of Myositis-Specific Autoantibodies and the Management of Interstitial Lung Disease in Idiopathic Inflammatory Myopathies: A Systematic Review	17
The control group matters: Pain, physical function and strength improvements relative to the comparator intervention in knee and hip osteoarthritis	17
Multiple morbidities are associated with serious infections in patients with rheumatoid arthritis	17
Comparison of disease activity index for psoriatic arthritis (DAPSA) and minimal disease activity (MDA) targets for patients with psoriatic arthritis: A post hoc analysis of data from phase 3 tofaciti	17
Advances in Targeted Therapies (ATT) What's cooking in the academic's kitchen? 3TR (IMI)	16
Effects of exercise-based interventions on inflammatory markers in patients with fibromyalgia: A systematic review and meta-analysis	16
Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysis	16
CAR T-cell therapy in SLE: A systematic review	16
Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial	16
Molecular mechanisms underlying thrombosis in systemic lupus erythematosus – A Systematic review	16
Comment on: Miedany et al. Beyond the symptoms: Personalizing giant cell arteritis care through multidimensional patient reported outcome measure	16
COVID-19 outcomes in patients with Dermatomyositis: A registry-based cohort analysis	15
Response to: ‘Critical Commentary ‘Infectious complications of Belimumab with standard care in systemic lupus erythematosus: A systematic review and meta-analysis’ by Saketh Sainag Mandiga et al	15
Association between Kawasaki disease and subsequent autoimmune disease: National cohort study of adolescents with 12-year follow-up from birth	15
Re: comment on: Miedany et al. response letter: Beyond the symptoms: personalizing giant cell arteritis care through multidimensional patient reported outcome measure. Volume 75, December 2025, 152844	15
Effects of neuromuscular control and strengthening exercises on MRI-measured thigh tissue composition and muscle properties in people with knee osteoarthritis – an exploratory secondary analysis from	15
Comments on the article by Goldman et al.	15
Reply on: International, multidisciplinary Delphi consensus recommendations on non-pharmacological interventions for fibromyalgia	15
Is glucocorticoid bridging therapy associated with later use of glucocorticoids and biological DMARDs during the disease course of patients with rheumatoid arthritis in daily practice? A real-world da	15
Juvenile and adult-onset scleroderma: Different clinical phenotypes	15
Correspondence to 'Nailfold capillaroscopy as a predictor of major cardiovascular events and mortality in systemic sclerosis'	15
Prognostic factors in giant cell arteritis associated aortitis with PET/CT and CT angiography at diagnosis	15
Comparison between rheumatoid arthritis with malignant lymphoma and other malignancies: Analysis of a National Database of Rheumatic Disease in Japan	15
Co-occurrence of giant cell arteritis in patients with polymyalgia rheumatica. Comment on the article by Nielsen AW, et al	15
Autoinflammatory syndromes with coexisting variants in Mediterranean FeVer and other genes: Utility of multiple gene screening and the possible impact of gene dosage	15
Autonomic dysfunction symptoms in Sjögren’s Disease: A missed dimension linked to disease burden and work disability	15
Synovial fibroblasts in juvenile idiopathic arthritis: A scoping review	15
Male rheumatoid arthritis patients at substantially higher risk for cardiovascular mortality in comparison to women	15
Biologics in peripheral ulcerative keratitis	15
Preventive effect of beta-blockers in the development of aortic dilation in giant cell arteritis-related aortitis	14
Predicting anxiety and depression in systemic lupus erythematosus: the role of inflammation, sociodemographic variables and clinical factors	14
Definitions and online reliability assessment of elementary ultrasound lesions in Takayasu arteritis: a study from the OMERACT Ultrasound Working Group	14
Self-esteem, self-concept, and body image of young people with rheumatic and musculoskeletal diseases: A systematic literature review	14
Response to the letter entitled " Letter to the editor to Soluble CXCL16 is a prognostic biomarker associated with rapidly progressive interstitial lung disease complicated with dermatomyositis" by Ga	14
Efficacy, safety, and cost-effectiveness of therapeutic drug monitoring (TDM) for TNF inhibitor therapy in rheumatic disease: A systematic review and meta-analysis	14
Factors associated with cardiovascular events in systemic lupus erythematosus in a monocentric cohort with up to 40 years of follow-up	14
Methotrexate use reduces mortality risk in rheumatoid arthritis: A systematic review and meta-analysis of cohort studies	14
Algorithmic approaches in hand imaging for rheumatic musculoskeletal diseases: A systematic literature review	14
An analysis of the first relapse in giant cell arteritis using ultrasonography	14
Defining domains: developing consensus-based definitions for foundational domains in OMERACT core outcome sets	14
Identification of outcome domains in immune checkpoint inhibitor-induced inflammatory arthritis and polymyalgia rheumatica: A scoping review by the OMERACT irAE working group	14
Modelling long-term outcomes for patients with systemic lupus erythematosus	14
Erratum to “Magnetic resonance imaging for adult idiopathic inflammatory myopathies: a scoping review of protocols, grading systems and applications”[Seminars in Arthritis and Rheumatism Volume 75, (2	14
Response to Letter concerning article entitled "Central sensitization has major impact on quality of life in patients with axial spondyloarthritis	14
Subclinical coronary artery calcification in systemic sclerosis using high-resolution chest CT: Identification, extent, and disease-specific risk factors	13
Cognitive impairment and other neuropsychiatric manifestations in patients with primary vasculitis: a systematic review	13
Defining patient perception of overall well-being and disease activity in the OMERACT Juvenile Idiopathic Arthritis (JIA) core domain set: A report from the JIA working group	13
Rheumatoid arthritis and the risk of 90-day readmission after hospitalization for heart failure	13
Does the time to the onset of lupus nephritis impact renal disease presentation and outcomes?	13
How is early spondyloarthritis defined in the literature? Results from a systematic review	13
Psychometric properties of patient-reported outcomes measurement information system (PROMIS) fixed short forms in Juvenile Myositis	13
Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus	13
Predicting best treatment in rheumatoid arthritis	13
Autoimmune rheumatic disease in Australian Aboriginal and Torres Strait Islander Peoples: What do we know?	13
Hormone therapy in menopause increases rheumatoid arthritis risk: A systematic review and meta-analysis	13
Acknowledgement of Referees	13
Giant cell arteritis-related stroke in a large inception cohort: A comparative study	13
Relapses in giant cell arteritis treated with tocilizumab. Retrospective multicenter study of 407 patients in clinical practice	13
Developing efficient predictive models for the diagnosis of VEXAS syndrome	12
Minimally invasive interventional procedures for osteoarthritis and inflammatory arthritis: A systematic review and meta-analysis	12
Risk of new onset of immune-mediated diseases after SARS-CoV-2 infection: A systematic review and meta-analysis	12
Risk of incident gout following exposure to recombinant zoster vaccine in US adults aged ≥65 years	12
Diffuse idiopathic skeletal hyperostosis in the oncologic population: a cross-sectional analysis of 1053 patients	12
Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials	12
Efficacy and safety of pharmacological treatments for autoimmune disease-associated interstitial lung disease: A systematic review and network meta-analysis	12
Characteristics and long-term outcomes of patients with rheumatoid arthritis and concurrent calcium pyrophosphate deposition disease	12
Efficacy and safety of anti-Tumor Necrosis Factor-α biosimilars in Juvenile Idiopathic Arthritis - a systematic review and meta-analysis	12
Remission in gout is possible: 5-year follow-up in the NOR-Gout study	12
Age of onset of rheumatoid arthritis and radiographic changes	12
Outcomes in ANCA-associated vasculitis patients with end-stage kidney disease on renal replacement therapy—A meta-analysis	12
Aortic disease in giant cell arteritis	12
Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study	12
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain set	12
Unraveling the role of neutrophil extracellular traps in rheumatoid arthritis: From triggers to therapeutic targets	12
Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis	12

The natural history of end-stage knee osteoarthritis: Data from the osteoarthritis initiative	12
Critical commentary: Factors associated with thrombosis in Behçet syndrome: A systematic review and meta-analysis	12
The prognostic power of anti-topoisomerase I and anti-centromere antibodies in systemic sclerosis - A systematic review of the literature	12
Does body mass index mediate the relationship between socioeconomic position and incident osteoarthritis?	12
Giant cell arteritis – New treatment targets at the horizon	11
Risk factors for the progression of rheumatoid arthritis-related interstitial lung disease: Clinical features, biomarkers, and treatment options	11
Rheumatologist and patient perspectives on axial spondyloarthritis management and treatment satisfaction in Europe	11
COVID-19 vaccination and systemic autoimmune rheumatic diseases: No evidence of disproportionately increased reporting in VAERS	11
Assessment of triple antiphospholipid antibody-positive patients based on clinical and laboratory domains of 2023 ACR/EULAR antiphospholipid syndrome classification criteria	11
Impact of previous glucocorticoid therapy on diagnostic accuracy of [18F] FDG PET-CT in giant cell arteritis	11
Treatment strategies and outcomes in adult relapsing or refractory cutaneous IgA Vasculitis: A multicenter retrospective cohort study	11
Telemedicine in rheumatology care: A systematic review	11
Severity and mortality of COVID-19 in patients with systemic sclerosis: a Brazilian multicenter study	11
Prevalence of frailty and prefrailty in systemic lupus erythematosus: A systematic review and meta-analysis	11
Reassessing the prevalence of monophasic, polyphasic and persistent disease courses in still’s disease	11
Determining the best discriminatory physical functioning outcome measurement instrument for psoriatic arthritis trials: A meta-epidemiological study	11
Immunosuppressive therapy to treat newly diagnosed primary heart involvement in patients with systemic sclerosis: An Italian cardiac magnetic resonance based study	11
COVID-19 vaccinations and infections among individuals with systemic sclerosis: A Scleroderma Patient-centered Intervention Network (SPIN) Cohort study	10
Impact of biologics on health-related quality of life in patients with Ankylosing spondylitis: A systematic review and meta-analysis of randomized controlled trials	10
Patient perspectives on long-term outcomes in rheumatoid arthritis. A qualitative study from the OMERACT patient outcomes in longitudinal studies working group	10
[18F]Sodium Fluoride PET has the potential to identify active formation of calcinosis cutis in limited cutaneous systemic sclerosis	10
Clinical association of health-related quality of life and mortality in an antineutrophil cytoplasmic antibody-associated vasculitis cohort	10
Definitions of rheumatoid arthritis flare and how they relate to patients’ perspectives: A scoping review of qualitative and quantitative evidence	10
Racial differences in persistent glucocorticoid use patterns among medicaid beneficiaries with incident systemic lupus erythematosus	10
Reply to: Expanding the role of mycophenolic acid in pediatric lupus nephritis: A holistic approach to extrarenal findings, side effects, and long-term outcomes	10
Pulmonary manifestations of granulomatosis with polyangiitis and microscopic polyangiitis	10
Neuropathic pain in spondyloarthritis: Decoding its prevalence, risk factors, and impact on disease activity	10
SAPHO syndrome: Patient stratification and the new horizon of precision medicine	10
Sodium-glucose cotransporter 1 inhibition and gout: Mendelian randomisation study	10
Trends in adverse pregnancy outcomes among women with systemic sclerosis in the United States	10
Taper versus discontinuation of tocilizumab in patients with giant cell arteritis: Real-world experience from a tertiary center	10
Patients’ perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group	10
Prevalence and risk factors of antinuclear antibodies among pregnant women: A cross-sectional study in Qingdao, China	10
Measurement properties of the decisional conflict scale in people living with chronic non-cancer pain: a secondary analysis of the DECIDE-PAIN pan-Canadian survey	10
Effectiveness and safety of anti-CD20 monoclonal antibodies versus csDMARDs in anti-Jo-1 antisynthetase syndrome: A retrospective cohort study	10
Evolution of bone lesions in adults with chronic nonbacterial osteitis (CNO): A long-term follow-up study	9
Sleep disorders in rheumatoid arthritis: Incidence, risk factors and association with dementia	9
The immune pathology of bursitis in rheumatic inflammatory diseases, degenerative conditions and mechanical stress: A systematic review	9
Effects of cumulative lifetime estrogen exposure on the clinical characteristics and courses in postmenopausal women with rheumatoid arthritis	9
Early-onset juvenile dermatomyositis: A tertiary referral center experience and review of the literature	9
Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study	9
Polygenic risk scores	9
Macrophages–Autoimmunity–Treatment option	9
Comparing Raynaud’s phenomenon attack measurement tools: paper or smartphone application?	9
Diffuse idiopathic skeletal hyperostosis (DISH) and trabecular bone score (TBS) in postmenopausal women: The Camargo cohort	9
Joint and muscle inflammatory disease: A scoping review of the published evidence	9
Validation studies of rheumatoid arthritis patient-reported outcome measures in populations at risk for inequity: A systematic review and analysis using the OMERACT summary of measurement properties e	9
Comprehensive analysis of disease activity, neuropsychiatric symptoms, imaging features and risk factors for seizure in hospitalized patients with juvenile-onset neuropsychiatric systemic lupus erythe	9
Increasing uptake through collaboration in the development of core outcome sets: Lessons learned at OMERACT 2023	9
Identifying domains for CNO and SAPHO: A scoping review to create domains from existing outcomes by the OMERACT CNO and SAPHO working group	9
Risk of ILD and safety outcomes across DMARD classes in rheumatoid arthritis and RA-ILD	9
Strategies to promote implementation of core outcomes for medication adherence trials in rheumatology: A report from the OMERACT-Adherence Group	9
Corrigendum to The Glucocorticoid Toxicity Index: Measuring Change in Glucocorticoid Toxicity Over Time [Seminars in Arthritis and Rheumatism Volume 55, 152010]	9
Immune checkpoint inhibitors and rheumatoid arthritis: All roads lead to PD-1?	9
Effect modification by contextual factors of urate-lowering therapy on serum urate in people with gout: A systematic review with meta-regression analysis	9
Adipocytokines and achievement of low disease activity in rheumatoid arthritis	9
Reply on: a meta-analysis of clinical manifestations in asian systemic lupus erythematous: The effects of ancestry, ethnicity and gender	8
Comment on "Risk and temporal trends of heart failure subtypes in rheumatoid arthritis"	8
Bone and entheseal targets for growth factors in diffuse idiopathic skeletal hyperostosis	8
Role of intravenous immunoglobulins in systemic sclerosis (SSc): A systematic literature review	8
Development of a prediction model for poor prognosis in childhood-onset Takayasu's arteritis	8
Effects of secukinumab on synovitis and enthesitis in patients with psoriatic arthritis: 52-week clinical and ultrasound results from the randomised, double-blind ULTIMATE trial with open label extens	8
Raynaud’s phenomenon is associated with an increased risk of cardiovascular disease and venous thromboembolism	8
Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies	8
Serological Stratification by Anti-Ro52 and Anti-Ro60 Profiles Reveals Distinct Systemic Phenotypes in Primary Sjögren's Disease	8
Referees	8
The use of ASDAS to evaluate disease activity and response to treatment in patients with axial spondyloarthritis starting the first biological drug: Are ASAS recommendations being followed?	8
Post-hoc analysis of two gout remission definitions in a two-year randomized controlled trial of nurse-led versus usual gout care	8
Management of disease progression after autologous hematopoietic stem cell transplantation in systemic sclerosis: Results from an international questionnaire-based study	8
Navigating the path of progress: The OMERACT 2023 emerging leaders program	8
Healthy dietary pattern and risk of rheumatoid arthritis: A systematic review and meta-analysis	8
Differences in the autoantibody phenotypes and long-term outcomes between juvenile- and adult-idiopathic inflammatory myopathies	8
Why most (but perhaps not all) DMARDs work equally well	8
An updated systematic review and meta-analysis of randomised controlled trials on the effects of urate-lowering therapy initiation during a gout flare	8
Moving urate-lowering therapy in gout beyond guideline recommendations	8
Pregnancy outcomes in 1869 pregnancies in a large cohort from the Spanish Society of Rheumatology Lupus Register (RELESSER)	8
Identification of outcome domains in primary Sjögren's disease: A scoping review by the OMERACT Sjögren disease working group	8
Serum ferritin as a significant biomarker for patients with idiopathic inflammatory myopathy-associated interstitial lung disease: A systematic review and meta-analysis	8
Reply: Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A systematic review and meta-analysis	8
Ultra-high frequency ultrasound for digital arteries: improving the characterization of vasculopathy in systemic sclerosis	8
Author Reply to Letter to the Editor	8
Factors associated with thrombosis in Behçet Syndrome: A systematic review and meta-analysis	8
Does smoking protect against developing osteoarthritis? Evidence from a genetically informed perspective	8
Risk of major adverse cardiovascular events following targeted therapy in patients with rheumatoid arthritis: a real-world analysis stratified by cardiovascular risk	8
Come rain or shine: Is weather a risk factor for musculoskeletal pain? A systematic review with meta-analysis of case-crossover studies	8
Traditional laboratory parameters and IFNγ-related biomarkers in the diagnosis and management of MAS	8
Reply to letter to the editor	8
Characteristics Of Difficult-To-Treat Psoriatic Arthritis: A Comparative Analysis	8
Brain white matter microstructural alterations in Behcet's syndrome correlate with cognitive impairment and disease severity: A diffusion tensor imaging study	8
2025 Consensus-based recommendations for the referral, diagnosis, monitoring, and management of axial spondyloarthritis in the Arabian Gulf countries	8
CNO/SAPHO: is it time for new serological biomarkers?	8
Menopausal hormone therapy and risk of seropositive rheumatoid arthritis: A nationwide cohort study in Korea	8
Scoping literature review to identify candidate domains for the OMERACT Systemic Lupus Erythematosus core outcome set	8